Cargando…
Targeted therapy against Bcl-2-related proteins in breast cancer cells
INTRODUCTION: Bcl-2 and Bcl-xL confer resistance to apoptosis, thereby reducing the effectiveness of chemotherapy. We examined the relationship between the expression of Bcl-2 and Bcl-xL and chemosensitivity of breast cancer cells, with the aim of developing specific targeted therapy. METHODS: Four...
Autores principales: | Emi, Manabu, Kim, Ryungsa, Tanabe, Kazuaki, Uchida, Yoko, Toge, Tetsuya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410745/ https://www.ncbi.nlm.nih.gov/pubmed/16280040 http://dx.doi.org/10.1186/bcr1323 |
Ejemplares similares
-
Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells
por: Emi, Manabu, et al.
Publicado: (2019) -
Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Clinical Perspectives in Addressing Unsolved Issues in (Neo)Adjuvant Therapy for Primary Breast Cancer
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Reconsidering the Meaning of Curing Primary Breast Cancer as a Systemic Disease
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Thoracoscopic double-flap reconstruction for esophagogastric junction cancer: A case report
por: Ohsawa, Manato, et al.
Publicado: (2020)